REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 168 filers reported holding REPLIGEN CORP in Q4 2014. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $27,000 | +22.7% | 145 | +72.6% | 0.07% | +102.8% |
Q4 2021 | $22,000 | -95.8% | 84 | -95.3% | 0.04% | -96.0% |
Q3 2021 | $521,000 | +12.0% | 1,803 | -24.7% | 0.90% | -2.9% |
Q1 2021 | $465,000 | +1.5% | 2,394 | +0.2% | 0.93% | -5.5% |
Q4 2020 | $458,000 | +35.5% | 2,389 | +4.4% | 0.98% | +29.1% |
Q3 2020 | $338,000 | -22.3% | 2,289 | -34.9% | 0.76% | +108.2% |
Q2 2020 | $435,000 | +22.9% | 3,517 | -4.1% | 0.37% | -2.9% |
Q1 2020 | $354,000 | -7.3% | 3,667 | -11.2% | 0.38% | +8.0% |
Q4 2019 | $382,000 | +21.7% | 4,128 | +0.9% | 0.35% | +8.4% |
Q3 2019 | $314,000 | -13.3% | 4,091 | -2.7% | 0.32% | -12.7% |
Q2 2019 | $362,000 | +44.2% | 4,206 | -0.8% | 0.37% | +41.4% |
Q1 2019 | $251,000 | +12.1% | 4,241 | -0.1% | 0.26% | -13.6% |
Q4 2018 | $224,000 | -59.4% | 4,244 | -78.6% | 0.30% | +76.6% |
Q3 2015 | $552,000 | +1625.0% | 19,817 | +1135.5% | 0.17% | +968.8% |
Q4 2014 | $32,000 | +28.0% | 1,604 | +26.1% | 0.02% | +23.1% |
Q3 2014 | $25,000 | – | 1,272 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |